Referencias

Bhargava, H., M.D. (2018, September 20).

Opioid (Narcotic) Pain Medications. Retrieved November 12, 2018, from

https://www.webmd.com/pain-management/guide/narcotic-pain-medications#1

Caitlin Conrad, B.S., Jessica Gentry, M.A,
et. al. (2016) “HIV Infection Linked to Injection Use of Oxymorphone in
Indiana” New England Journal of Medicine 375:229-239 DOI:10.1056/NEJMoa1515195

Canan, C. E., Chander, G., Monroe, A. K.,
Gebo, K. A., Moore, R. D., Agwu, A. L., . . . HIV, N. E. (2018, July 01).
High-Risk Prescription Opioid Use Among People Living With HIV. Retrieved from
https://www.ncbi.nlm.nih.gov/pubmed/29601405

Dawson, L., & Kates, J. (2018, April
12). HIV and the Opioid Epidemic: 5 Key Points. Retrieved from
https://www.kff.org/hivaids/issue-brief/hiv-and-the-opioid-epidemic-5-key-points/

Hansen, H., MD, & Netherland, J., PhD.
(2016). Is the Prescription Opioid Epidemic a White Problem? American
Journal of Public Health,106(12), 2127-2129. doi:10.2105/AJPH.2016.303483 

Higgins, C., Smith, B. H., & Matthews,
K. (2018). Evidence of opioid-induced hyperalgesia in clinical populations
after chronic opioid exposure: A systematic review and meta-analysis
[Abstract]. British Journal of Anaesthesia.
doi:https://doi.org/10.1016/j.bja.2018.09.019

Huang, B., Dawson, D. A., Stinson, F. S.,
Hasin, D. S., Ruan, W. J., Saha, T. D., . . . Grant, B. F. (2006). Prevalence,
correlates, and comorbidity of nonmedical prescription drug use and drug use
disorders in the United States: Results of the National Epidemiologic Survey on
Alcohol and Related Conditions. The Journal of Clinical Psychiatry, 67(7),
1062-1073. doi:10.4088/JCP.v67n0708

Hudak, M. L., & Tan, R. C. (2012).
Neonatal Drug Withdrawal. American Academy of Pediatrics, 129,
540-560. DOI:10.1542/peds.2011-3212

Jezek, A., & Weddle, A. (2018).
Infectious Diseases and Opioid Use Disorder (OUD) Policy Issues and Recommendations.
Infectious Diseases Society of America News, 1-8. Retrieved from
https://www.idsociety.org/globalassets/idsa/news-and-publication/press-releases/2018/id-and-the-opioid-epidemic-policy-brief_3-19-2018-updated.pdf.

Jones, A. A., Striley, C. W. and Cottler,
L. B. (2016) “Prescription opioid use, illicit drug use, and sexually
transmitted infections among participants from a community engagement program
in North Central Florida” Journal of Substance Use 22:1, 90-95,
DOI: 10.3109/14659891.2016.1144805

Lin, J. C., Chu, L. F., Stringer, E. A.,

Baker, K. S., Sayyid, Z. N., Sun, J., . . . Younger, J. W. (2015). One Month of
Oral Morphine Decreases Gray Matter Volume in the Right Amygdala of Individuals
with Low Back Pain: Confirmation of Previously Reported Magnetic Resonance
Imaging Results. Pain Medicine, 17(8), 1497-1504.
doi:10.1093/pm/pnv047

Lutz, P., Courtet, P., & Calati, R.
(2018). The opioid system and the social brain: Implications for depression and
suicide. Journal of Neuroscience Research, 1-13. doi:10.1002/jnr.24269

Mateu-Gelabert, Pedro et al. (2014)
“Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of
prescription opioids among young adults in New York City” Journal of
Substance Abuse Treatment , Volume 48 , Issue 1 , 13 - 20, DOI: https://doi.org/10.1016/j.jsat.2014.07.002

Naik, P., Cashin, L. & Huitron, S.
(2016) A Case of Pulmonary Foreign Body Granulomatosis Secondary to Intravenous
Injection of Acetaminophen/Oxycodone. Military medicine, 181(10),
1404-1406. https://doi.org/10.7205/MOLMED-D-1500486

National Institute on Drug Abuse. (2018,
March 06). Opioid Overdose Crisis. Retrieved from
https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis#seven

NCHHSTP Newsroom. (2017, December 21). Retrieved from
https://www.cdc.gov/nchhstp/newsroom/2017/hepatitis-c-and-opioid-injection.html

Netto, A. D., Carvalho, F., &
Dinis-Oliveira, R. J. (2015). The harmful chemistry behind krokodil
(desomorphine) synthesis and mechanisms of toxicity. Forensic Science
International,249, 207-213. doi:10.1016/j.forsciint.2015.02.001

Olsen, Y., MD, MPH, & Sharfstein, J.
M., MD. (2014). Confronting the Stigma of Opioid Use Disorder— and Its
Treatment. Journal of American Medical Association, 311(14),
1393-1394.

Poon, A. F., & Dearlove, B. L. (2018).
Quantifying the Aftermath: Recent Outbreaks Among People Who Inject Drugs and
the Utility of Phylodynamics. Journal of Infectious Diseases, 217(12),
1854-1857. DOI:  https://doi.org/10.1093/infdis/jiy132

Pacheco, A., & Esteves, M. (2011,

January 19). A Study of the Sexuality of Opiate Addicts. Retrieved from https://www.tandfonline.com/doi/abs/10.1080/00926230290001547

Research on the Use and Misuse of Fentanyl

and Other Synthetic Opioids, House Committee on Energy and Commerce
Cong. (2017) (testimony of Wilson M. Compton, M.D.).

Tara Vogt, Bridget A Wyn, et. al. (2012)

“Integrated Prevention Services for HIV Infection, Viral Hepatitis, Sexually
Transmitted Diseases, and Tuberculosis for Persons Who Use Drugs Illicitly:
Summary Guidance from CDC and the U.S. Department of Health and Human Services”
Morbidity and Mortality Weekly Report: Recommendations and Reports Vol. 61, No. 5, pp. 1-43; http://www.jstor.org/stable/24832539

Van Ryswyk, E., & Antic, N. A. (2016). Opioids
and Sleep-Disordered Breathing. CHEST, 150(4),
934-944. http://dx.doi.org/10.1016/j.chest.2016.05.022

Wang, L., Zou, F., Zhai, T., Lei, Y., Tan,
S., Jin, X., . . . Yang, Z. (2015). Abnormal gray matter
volume and resting-state functional connectivity in former heroin-dependent
individuals abstinent for multiple years. Addiction Biology, 21(3),
646-656. doi:10.1111/adb.12228

Wollman, S. C., Alhassoon, O. M., Hall, M.
G., Stern, M. J., Connors, E. J., Kimmel, C. L., . . . Radua, J. (2016). Gray
matter abnormalities in opioid-dependent patients: A neuroimaging
meta-analysis. The American Journal of Drug and Alcohol Abuse, 43(5),
505-517. doi:10.1080/00952990.2016.1245312

Wu, L., Woody, G. E., Yang, C., &Blazer, D. G. (2011). How do prescription opioid users differ from users of heroin or other drugs in psychopathology: Results from the National Epidemiologic
Survey on Alcohol and Related Conditions. Journal of Addiction Medicine,
5(1), 28-35. DOI:10.1097/ADM.0b013e3181e0364e

Zwicker, J. G., Miller, S. P., Grunau, R. E., Chau, V., Brant, R., Studholme,

C., . . . Tam, E. W. (2016). Smaller Cerebellar Growth and Poorer
Neurodevelopmental Outcomes in Very Preterm Infants Exposed to Neonatal
Morphine. The Journal of Pediatrics, 172. doi:10.1016/j.jpeds.2015.12.024